Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation

BACKGROUND: Frailty predicts poorer outcomes and decreased anticoagulation use in patients with nonvalvular atrial fibrillation. We sought to assess the effectiveness and safety of apixaban, dabigatran and rivaroxaban versus warfarin in frail nonvalvular atrial fibrillation patients. METHODS AND RES...

Full description

Saved in:
Bibliographic Details
Published in:J Am Heart Assoc
Main Authors: Martinez, Brandon K., Sood, Nitesh A., Bunz, Thomas J., Coleman, Craig I.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2018
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6015429/
https://ncbi.nlm.nih.gov/pubmed/29654196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.008643
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items